Market Cap ₹3 Cr.
Stock P/E 0.0
P/B -
Current Price ₹1.3
Book Value ₹ 0
Face Value 10
52W High ₹2.3
Dividend Yield 0%
52W Low ₹ 1.1
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) |
---|
Net Sales |
Other Income |
Total Income |
Total Expenditure |
Operating Profit |
Interest |
Depreciation |
Exceptional Income / Expenses |
Profit Before Tax |
Provision for Tax |
Profit After Tax |
Adjustments |
Profit After Adjustments |
Adjusted Earnings Per Share |
#(Fig in Cr.) | Mar 2019 | Mar 2020 | TTM |
---|---|---|---|
Net Sales | 156 | 43 | |
Other Income | 1 | 0 | |
Total Income | 157 | 43 | |
Total Expenditure | 252 | 53 | |
Operating Profit | -95 | -10 | |
Interest | 36 | 38 | |
Depreciation | 9 | 9 | |
Exceptional Income / Expenses | -35 | 0 | |
Profit Before Tax | -175 | -57 | |
Provision for Tax | 2 | 0 | |
Profit After Tax | -177 | -57 | |
Adjustments | 0 | 0 | |
Profit After Adjustments | -177 | -57 | |
Adjusted Earnings Per Share | -75.5 | -24.4 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | -72% | 0% | 0% | 0% |
Operating Profit CAGR | 0% | 0% | 0% | 0% |
PAT CAGR | 0% | 0% | 0% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | -17% | 7% | -2% | -25% |
ROE Average | 0% | 0% | 0% | 0% |
ROCE Average | -16% | -65% | -65% | -65% |
#(Fig in Cr.) | Mar 2019 | Mar 2020 |
---|---|---|
Shareholder's Funds | -153 | -210 |
Minority's Interest | 0 | 0 |
Borrowings | 18 | 22 |
Other Non-Current Liabilities | 13 | 13 |
Total Current Liabilities | 320 | 366 |
Total Liabilities | 198 | 190 |
Fixed Assets | 111 | 102 |
Other Non-Current Assets | 3 | 0 |
Total Current Assets | 85 | 89 |
Total Assets | 198 | 190 |
#(Fig in Cr.) | Mar 2019 | Mar 2020 |
---|---|---|
Opening Cash & Cash Equivalents | 9 | 4 |
Cash Flow from Operating Activities | -36 | -10 |
Cash Flow from Investing Activities | -3 | 1 |
Cash Flow from Financing Activities | 34 | 11 |
Net Cash Inflow / Outflow | -5 | 2 |
Closing Cash & Cash Equivalent | 4 | 6 |
# | Mar 2019 | Mar 2020 |
---|---|---|
Earnings Per Share (Rs) | -75.46 | -24.45 |
CEPS(Rs) | -71.51 | -20.55 |
DPS(Rs) | 0 | 0 |
Book NAV/Share(Rs) | -65.22 | -89.67 |
Core EBITDA Margin(%) | -61.59 | -25.04 |
EBIT Margin(%) | -89.58 | -45.31 |
Pre Tax Margin(%) | -112.52 | -134.38 |
PAT Margin (%) | -113.58 | -134.41 |
Cash Profit Margin (%) | -107.63 | -112.97 |
ROA(%) | -89.27 | -29.51 |
ROE(%) | 0 | 0 |
ROCE(%) | -113.07 | -16.36 |
Receivable days | 109.01 | 391.83 |
Inventory Days | 27.72 | 118 |
Payable days | 72.34 | 738.64 |
PER(x) | 0 | 0 |
Price/Book(x) | -0.02 | -0.01 |
Dividend Yield(%) | 0 | 0 |
EV/Net Sales(x) | 1.77 | 7.45 |
EV/Core EBITDA(x) | -2.91 | -31.22 |
Net Sales Growth(%) | 0 | -72.62 |
EBIT Growth(%) | 0 | 86.15 |
PAT Growth(%) | 0 | 67.6 |
EPS Growth(%) | 0 | 67.6 |
Debt/Equity(x) | -1.81 | -1.54 |
Current Ratio(x) | 0.27 | 0.24 |
Quick Ratio(x) | 0.23 | 0.2 |
Interest Cover(x) | -3.91 | -0.51 |
Total Debt/Mcap(x) | 79.61 | 281.12 |
# | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 59.41 | 59.41 | 59.41 | 59.41 | 59.41 | 59.41 | 59.41 | 59.41 | 59.41 | 59.41 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 40.59 | 40.59 | 40.59 | 40.59 | 40.59 | 40.59 | 40.59 | 40.59 | 40.59 | 40.59 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2020 | Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 1.39 | 1.39 | 1.39 | 1.39 | 1.39 | 1.39 | 1.39 | 1.39 | 1.39 | 1.39 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 | 0.95 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 2.34 | 2.34 | 2.34 | 2.34 | 2.34 | 2.34 | 2.34 | 2.34 | 2.34 | 2.34 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About